From the publishers of JADPRO

Bone Protection Resource Center

Advertisement
News & Literature Highlights

Journal of Nuclear Medicine

mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: response to treatment and survival analysis

JAMA Open Network

Association of bone mineral density testing with risk of major osteoporotic fractures among older men receiving androgen deprivation therapy to treat localized or regional prostate cancer

Journal of Clinical Oncology

Impact of the oncology care model on use of supportive care medications during cancer treatment

Healthcare

Association between overall survival and activities of daily living in patients with spinal bone metastases

Cancers

Advancing treatment of bone metastases through novel translational approaches targeting the bone microenvironment

2022 ASCO Genitourinary Cancers Symposium (Abstract)

Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial.

2022 ASCO Genitourinary Cancers Symposium (Abstract)

Improvements in symptoms related to bone metastasis in recipients of Lutetium-177 PSMA-617 for prostate cancer

Irish Journal of Medical Science

The efficacy of a comprehensive bone health program in maintaining bone mineral density in postmenopausal women with early-stage breast cancer treated with endocrine therapy: real-world data

Supportive Care in Cancer

Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers

Oncology Nurse Advisor

Strategies for managing chronic pain in patients with bone-metastatic CRPC

Advertisement
Advertisement